Enrollment in Sirolimus 309 began in April, 1998 and closed in September, 1998. During this time, we enrolled twenty-one patients. Of the twenty-one we are continuing to follow fifteen patients, all of whom have functioning grafts. Results are consistent with what is expected in this transplant population.
Showing the most recent 10 out of 343 publications